image
Healthcare - Biotechnology - NASDAQ - US
$ 0.3425
-5.66 %
$ 21.3 M
Market Cap
-0.32
P/E
CASH FLOW STATEMENT
-48 M OPERATING CASH FLOW
38.73%
54.9 M INVESTING CASH FLOW
-15.77%
8.87 M FINANCING CASH FLOW
6473.33%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Passage Bio, Inc.
image
00(20m)(20m)(40m)(40m)(60m)(60m)(80m)(80m)(100m)(100m)(120m)(120m)(140m)(140m)(160m)(160m)20192019202020202021202120222022202320232024202420252025
Net Income -64.8 M
Depreciation & Amortization 3.08 M
Capital Expenditures -34 K
Stock-Based Compensation 5.82 M
Change in Working Capital 4.2 M
Others 8.47 M
Free Cash Flow -48 M

Cash Flow

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018
OPERATING CASH FLOW
Net Income (64.8) (102.1) (136.1) (185.4) (112.2) (45.6) (12.8)
Depreciation & Amortization 3.1 3.7 3.7 1.5 0.8 0.1 0
Deferred Income Tax 0 0 0 2.8 0.6 9.1 0
Stock Based Compensation 5.8 10.9 19.0 32.7 14.6 1.5 0
Other Operating Activities 3.7 3.8 3.8 10.1 1.3 1.0 2.7
Change in Working Capital 4.2 5.3 (8.5) 11.4 14.4 (5.9) (8.5)
Cash From Operations (48.0) (78.3) (118.2) (126.9) (80.5) (39.9) (18.6)
INVESTING CASH FLOW
Capital Expenditures 34 K (0.1) (5.3) (25.6) (1.6) (1.7) (2.5)
Other Items 55.0 65.4 30.5 (20.2) (170.5) 0 0
Cash From Investing Activities 54.9 65.2 25.2 (45.8) (172.1) (1.7) (2.5)
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 0 0 0
Total Debt Repaid 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0
Other Financing Activities 0.1 0 (1.4) 37 K 0.3 175.6 46.0
Cash From Financing Activities 8.9 0.1 1.35 K 0.2 228.8 175.6 46.0
CHANGE IN CASH
Net Change In Cash 15.9 (12.9) (94.4) (6.0) (23.9) 134.0 24.9
FREE CASH FLOW
Free Cash Flow (48.0) (78.4) (123.5) (152.5) (82.2) (41.6) (21.1)